Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Invested Capital (2020 - 2025)

Agilon Health's Invested Capital history spans 6 years, with the latest figure at $161.7 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 69.84% year-over-year to $161.7 million; the TTM value through Dec 2025 reached $161.7 million, down 69.84%, while the annual FY2025 figure was $161.7 million, 69.84% down from the prior year.
  • Invested Capital reached $161.7 million in Q4 2025 per AGL's latest filing, down from $341.1 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.2 billion in Q2 2021 to a low of -$298.2 million in Q1 2021.
  • Average Invested Capital over 5 years is $760.3 million, with a median of $829.2 million recorded in 2023.
  • Peak YoY movement for Invested Capital: surged 564.81% in 2021, then crashed 69.84% in 2025.
  • A 5-year view of Invested Capital shows it stood at $1.1 billion in 2021, then dropped by 4.65% to $1.0 billion in 2022, then crashed by 33.1% to $699.5 million in 2023, then fell by 23.35% to $536.2 million in 2024, then plummeted by 69.84% to $161.7 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Invested Capital are $161.7 million (Q4 2025), $341.1 million (Q3 2025), and $408.9 million (Q2 2025).